Clinical Trials

    A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

    Investigator: Siddhartha Ganguly

    Study Coordinator: Danielle Sewall

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT05455320

    Phone: 346.238.2674

    Protocol Number: PRO00036193

    Description


    The purpose of the study is to compare the efficacy of talquetamab subcutaneous(ly) (SC) in combination with daratumumab SC and pomalidomide (Tal-DP) and talquetamab SC in combination with daratumumab SC (Tal-D), respectively, with daratumumab in combination with pomalidomide and dexamethasone (DPd).